Thank You GCRFThe OHSU Knight Cancer Institute presented a thank you award to Tania and Robert Stuntman and GCRF by Michael Heinrich, M.D. and Christopher Corless, M.D., Ph.D. at the Conference Highlighting Advancements in Gastrointestinal Stromal Tumors (GIST) Research on May 9, 2017.
Long-Term Survival Rates For GIST PatientsThe SWOG study shows strong long-term survival rates for patients with GIST. "This is a really exciting finding," said Dr. Michael Heinrich, a SWOG investigator and a professor of medicine and cell and developmental biology at Oregon Health & Science University, where SWOG is based.
Supporting The GIST Cancer Team of Doctors, Researchers & NursesGCRF is committed to supporting the GIST Cancer Team of Doctors, Researchers and Nurses who have dedicated their lives to the treatment and cure of this deadly cancer.
Thank You!The 2017 GCRF Walk For A Cure in New York was a great success thanks to the generous support of all who attended. Every dollar that was raised goes directly to GIST Cancer Research. For 2018, please tell your freinds and spread the word and let’s make it the largest gathering ever to support GIST Cancer Research. From all of us at GCRF, THANK YOU!
GCRF California’s Walk For A Cure Celebrates 10 Years!The 10th Annual GIST Cancer Research Fund’s 2017 Walk For A Cure is October 22, 2017 at Almaden Lake Park in San Jose, CA. We’re celebrating 10 years of raising funds, hope and awareness in the fight against GIST Cancer. Registration is at 9:30 and the Walk is 10:30 AM - 2:30 PM. Come on out and help us save lives!
GIST - A Rare Orphan Cancer
Gastrointestinal Stromal Tumor or GIST is a rare, orphan cancer which starts in a type of tissue called the stromal or the body’s connective tissue (fat, muscle, blood vessels, deep skin tissues, nerves, bones or cartilage). GIST is a silent cancer often spreading before the patient has symptoms. Each year, approximately 5,000 adults in the United States alone are diagnosed with GIST Cancer. The overall five year survival rate of people diagnosed with a malignant tumor has been estimated to be 76%.
Gastrointestinal Stromal Tumors (GISTs) are so rare that the exact number of people diagnosed with these tumors each year is not known. Until the late 1990s, not much research was available about these tumors and doctors didn’t have enough information or solid markers to identify them through testing. According to the American Cancer Society, many doctors misdiagnose GIST as another type of GI cancer. The lifesaving treatment for GIST was delayed and the GIST Cancer destroyed lives.
“One Life Lost is One Life Too Many”
Tania Stuntman was diagnosed with an extremely rare orphan cancer called gastrointestinal stromal tumor or GIST. It was so rare that questions on treatment, general information and survival rates couldn’t be found. She was told to give up but she refused. In 2001, Tania and her husband, Robert, founded the GIST Cancer Research Fund (GCRF) to provide support, counseling and awareness to the growing community of GIST patients, families and caregivers. The primary goal of GCRF is to raise much needed funds for GIST Cancer education, awareness and research to increase survival rates, expand life-saving therapies and most importantly, save lives.
Tell The World How You Feel About GIST Cancer
Spread Awareness & Join The Fight and Let’s Find A Cure!
By wearing and displaying GIST Cancer bracelets, ribbons and t-shirts, you are spreading a message and awareness to find a cure for this rare cancer. Remember 100% of all donations go directly to GIST Cancer Research.
Support the Gist Cancer Research Fund every time you shop, at no cost to you, with AmazonSmile. When you shop at smile.amazon.com, the AmazonSmile Foundation will donate 0.5% of the purchase price from your eligible AmazonSmile purchases. Remember that every time you make an Amazon purchase, you’re also supporting the GIST Cancer Research Fund and helping to find a cure for GIST Cancer.